Company registration number 07351791 (England and Wales)
BRUNEL MEDICAL SERVICES LIMITED
UNAUDITED FINANCIAL STATEMENTS
FOR THE PERIOD ENDED 31 MARCH 2025
PAGES FOR FILING WITH REGISTRAR
BRUNEL MEDICAL SERVICES LIMITED
CONTENTS
Page
Balance sheet
1 - 2
Statement of changes in equity
3
Notes to the financial statements
4 - 8
BRUNEL MEDICAL SERVICES LIMITED
BALANCE SHEET
AS AT
31 MARCH 2025
31 March 2025
- 1 -
31 March 2025
30 April 2024
Notes
£
£
£
£
Fixed assets
Tangible assets
3
791,326
794,496
Current assets
Debtors
4
2,539
44,496
Cash at bank and in hand
69,828
18,645
72,367
63,141
Creditors: amounts falling due within one year
Taxation and social security
18,793
17,700
Other creditors
17,795
2,100
36,588
19,800
Net current assets
35,779
43,341
Total assets less current liabilities
827,105
837,837
Provisions for liabilities
(14,090)
(5,205)
Net assets
813,015
832,632
Capital and reserves
Called up share capital
5
9,999
9,999
Revaluation reserve
97,411
106,941
Profit and loss reserves
705,605
715,692
Total equity
813,015
832,632
The directors of the company have elected not to include a copy of the profit and loss account within the financial statements.true
For the financial Period ended 31 March 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.
The members have not required the company to obtain an audit of its financial statements for the Period in question in accordance with section 476.
These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
BRUNEL MEDICAL SERVICES LIMITED
BALANCE SHEET (CONTINUED)
AS AT
31 MARCH 2025
31 March 2025
- 2 -
The financial statements were approved by the board of directors and authorised for issue on 16 December 2025 and are signed on its behalf by:
Dr R Veale
Director
Company Registration No. 07351791
BRUNEL MEDICAL SERVICES LIMITED
STATEMENT OF CHANGES IN EQUITY
FOR THE PERIOD ENDED 31 MARCH 2025
- 3 -
Share capital
Revaluation reserve
Profit and loss reserves
Total
Notes
£
£
£
£
Balance at 1 May 2023
9,999
106,941
735,724
852,664
Year ended 30 April 2024:
Profit and total comprehensive income for the year
-
-
66,968
66,968
Dividends
-
-
(87,000)
(87,000)
Balance at 30 April 2024
9,999
106,941
715,692
832,632
Period ended 31 March 2025:
Profit for the period
-
-
56,880
56,880
Other comprehensive income:
Tax relating to other comprehensive income
-
(9,530)
(9,530)
Total comprehensive income for the period
-
(9,530)
56,880
47,350
Dividends
-
-
(66,967)
(66,967)
Balance at 31 March 2025
9,999
97,411
705,605
813,015
BRUNEL MEDICAL SERVICES LIMITED
NOTES TO THE FINANCIAL STATEMENTS
FOR THE PERIOD ENDED 31 MARCH 2025
- 4 -
1
Accounting policies
Company information
Brunel Medical Services Limited is a private company limited by shares incorporated in England and Wales. The registered office is 3rd Floor Salt Quay House, North East Quay, Sutton Harbour, Plymouth, Devon, United Kingdom, PL4 0BN.
1.1
Reporting period
The company has changed its financial year end from 30 April to 31 March. These financial statements therefore cover an 11-month period from 1 May 2024 to 31 March 2025. This change was made to align the company’s reporting period with the UK tax year. As a result, the comparative amounts presented in these financial statements (including related notes) are not entirely comparable with the current period.
1.2
Accounting convention
These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.
The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.
The financial statements have been prepared under the historical cost convention. The principal accounting policies adopted are set out below.
1.3
Turnover
Turnover is recognised at the fair value of the consideration received or receivable for goods and services provided in the normal course of business.
Revenue from contracts for the provision of professional services is recognised by reference to the stage of completion when the stage of completion, costs incurred and costs to complete can be estimated reliably. The stage of completion is calculated by comparing costs incurred, mainly in relation to contractual hourly staff rates and materials, as a proportion of total costs. Where the outcome cannot be estimated reliably, revenue is recognised only to the extent of the expenses recognised that it is probable will be recovered.
1.4
Tangible fixed assets
Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.
Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:
Freehold buildings
Revaluation model applies
Fixtures and fittings
25% reducing balance
The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.
BRUNEL MEDICAL SERVICES LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE PERIOD ENDED 31 MARCH 2025
1
Accounting policies
(Continued)
- 5 -
Freehold property is to be held under the revaluation model and are carried at a revalued amount, being their fair value at the date of valuation less any subsequent accumulated depreciation and subsequent accumulated impairment losses. The fair value of the land and buildings is usually considered to be their market value.
Revaluation gains and losses are recognised in other comprehensive income and accumulated in equity, except to the extent that a revaluation gain reverses a revaluation loss previously recognised in profit or loss or a revaluation loss exceeds the accumulated revaluation gains recognised in equity; such gains and losses are recognised in profit or loss.
1.5
Financial instruments
The company has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments.
Financial instruments are recognised in the company's balance sheet when the company becomes party to the contractual provisions of the instrument.
Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.
Basic financial assets
Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.
Classification of financial liabilities
Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.
Basic financial liabilities
Basic financial liabilities, including creditors, bank loans, loans from fellow group companies and preference shares that are classified as debt, are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.
Debt instruments are subsequently carried at amortised cost, using the effective interest rate method.
Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Amounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade creditors are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method.
1.6
Taxation
The tax expense represents the sum of the tax currently payable and deferred tax.
BRUNEL MEDICAL SERVICES LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE PERIOD ENDED 31 MARCH 2025
1
Accounting policies
(Continued)
- 6 -
Current tax
The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the profit and loss account because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The company’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.
Deferred tax
Deferred tax liabilities are generally recognised for all timing differences and deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Such assets and liabilities are not recognised if the timing difference arises from goodwill or from the initial recognition of other assets and liabilities in a transaction that affects neither the tax profit nor the accounting profit.
2
Employees
The average monthly number of persons (including directors) employed by the company during the Period was:
2025
2024
Number
Number
Total
0
0
3
Tangible fixed assets
Land and buildings
Fixtures and fittings
Total
£
£
£
Cost
At 1 May 2024
770,000
93,434
863,434
Additions
2,622
2,622
At 31 March 2025
770,000
96,056
866,056
Depreciation and impairment
At 1 May 2024
68,938
68,938
Depreciation charged in the Period
5,792
5,792
At 31 March 2025
74,730
74,730
Carrying amount
At 31 March 2025
770,000
21,326
791,326
At 30 April 2024
770,000
24,496
794,496
BRUNEL MEDICAL SERVICES LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE PERIOD ENDED 31 MARCH 2025
3
Tangible fixed assets
(Continued)
- 7 -
Land and buildings with a carrying amount of £770,000 have been revalued by the directors with reference to a valuation undertaken in August and October 2020 by Stratton Creber, independent valuers not connected with the company on the basis of market value. The valuation has been prepared in accordance with the RICS Valuation - Global Standard.
If freehold property was measured using the cost model, the carrying amounts would have been approximately £663,059 (2024 - £663,059), being cost £663,059 (2024 - £663,059) and depreciation £nil (2024 - £nil).
4
Debtors
2025
2024
Amounts falling due within one year:
£
£
Trade debtors
2,539
2,882
Other debtors
41,614
2,539
44,496
5
Called up share capital
2025
2024
2025
2024
Ordinary share capital
Number
Number
£
£
Issued and fully paid
Ordinary E shares of £1 each
1,765
1,765
1,765
1,765
Ordinary F shares of £1 each
1,765
2,352
2,352
2,352
Ordinary J shares of £1 each
2,352
1,765
1,765
1,765
Ordinary H shares of £1 each
2,352
2,352
2,352
2,352
Ordinary I shares of £1 each
1,765
1,765
1,765
1,765
9,999
9,999
9,999
9,999
Rights, preferences and restrictions
The E, F, J, H and I ordinary shares have the following rights, preferences and restrictions:
The E, F, J, H and I ordinary shares all carry the same rights and privileges and rank pari passu in all respects, except that in respect of dividends. With regards to dividends, the directors shall not be bound to treat the E, F, J, H and I shares in the same manner.
6
Related party transactions
Transactions with related parties
During the Period the company entered into the following transactions with related parties:
The following amounts were outstanding at the reporting end date:
2025
2024
Amounts due (to)/from related parties
£
£
Other related parties
(15,795)
39,931
BRUNEL MEDICAL SERVICES LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE PERIOD ENDED 31 MARCH 2025
6
Related party transactions
(Continued)
- 8 -
Other information
Brunel Medical Practice
The directors of the company are partners of Brunel Medical Practice, or close family members of the partners.
During the year a loan account existed between the company and the Brunel Medical Practice. The company charged the partnership £60,000 (2024: £60,000) for management services in the year. The company also made advances to the partnership in the year amounting to £4,142 (2024: £67,491). Repayments were received from the partnership during the year amounting to £ 119,868 (2024: £118,834).